Description: Figure 83 shows that reduction in ovarian cancer mortality is the major contributor to favorable harm/benefit ratios in terms of mortality.

Figure 83Effect of specific benefits on harm/benefit acceptability for mortality (duration model only)

From: 5, Overall Benefits and Harms of Oral Contraceptives for Prevention of Ovarian Cancer

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.